medline.ch Gynäkologie Mammae

	Effects of dance therapy on anxiety, stress, optimism and depressive symptoms in women undergoing breast cancer surgery: a randomized clinical trial. J Bodyw Mov Ther Petzold Werle S, da Silveira J, de Azevedo Guimarães AC. PMID: 41316614 [PubMed - indexed for MEDLINE]
	Pathological response to pembrolizumab-based neoadjuvant therapy in ER-low vs. ER-zero breast cancer: a Swedish population-based cohort study. Breast Cancer Res Steen S, Karlsson E, Björnheden I, Rask G, Thurfjell V, Nobin H, Kolodziej B, Bodén A, Bauer A, Einefors R, Nilsson P, Zerdes I, Papakonstantinou A, Foukakis T, Fredriksson I, Rantalainen M, Colón-Cervantes E, Kovács A, Acs B, Hartman J. PMID: 41316480 [PubMed - as supplied by publisher]
	Psychological adjustment strategies used by Moroccan patients with locally advanced breast cancer to cope with the psychological impact of diagnosis and the effects of neoadjuvant chemotherapy: a qualitative study. BMC Psychiatry Nadi S, Omari M, Kriya S, El Asri A, Mellas N, Ragala MEA, Amaadour L, Zarrouq B. PMID: 41316112 [PubMed - as supplied by publisher]
	Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience. BMC Cancer Ba, , Ero, Efil SC, Kaya S, Tolunay PK, , Karaçin C, Yaz, , Öksüzo, Aksoy S. PMID: 41316060 [PubMed - indexed for MEDLINE]
	Knowledge and practice of self-examination among breast cancer patients in Tanzania: A cross-sectional study. Sci Rep Msoka EF, Mulder BC, Bright FB, Moshi B, Beavers A, Mitao M, Masenga GG, Gebremariam A, Kantelhardt EJ, Joffe M, Mmbaga BT. PMID: 41315840 [PubMed - as supplied by publisher]
	A pilot study of pre-diagnosis dietary patterns and lifestyle factors in physically active and inactive women with breast cancer. Sci Rep Gogojewicz A, Liszka M, Nowaczyk P, Siejak W, Bilska A, Radzimirska-Graczyk M, Malchrowicz-Mo, Popierz-Rydlewska N. PMID: 41315744 [PubMed - as supplied by publisher]
	Deep learning-based classification of benign and malignant breast microcalcifications in mammography. Sci Rep Shia WC. PMID: 41315645 [PubMed - indexed for MEDLINE]
	Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial. Nat Commun Waks AG, Fu J, Chu X, Binboga Kurt B, Li T, Kuntz TM, Shen Y, Yang D, Meli K, Reardon B, Park J, Partridge A, Abravanel D, Jeselsohn R, Wrabel E, Alberti J, DiLullo M, Chen S, Mohammed-Abreu A, Sun X, Balko JM, Kleijn M, Audeh W, Morgan XC, Krop IE, Tayob N, Van Allen EM, Mittendorf EA, Tolaney SM. PMID: 41315271 [PubMed - indexed for MEDLINE]
	Collagen dynamics in the breast cancer tumor microenvironment and therapeutic perspectives. Discov Oncol Wu D, Liu L, Jiang Y, Qian Z, You Y, Ning X, Zhang F, Wang Y, Zhang Y. PMID: 41315075 [PubMed - as supplied by publisher]
	Histologic Categorization of Desmoplastic Reaction in Triple-Negative Breast Cancer: Its Relevance to Neoadjuvant Chemoimmunotherapy Response and Tumor Biology. Mod Pathol Lu X, Luo B, Wei Y, Bu H, Gou Z. PMID: 41314289 [PubMed - as supplied by publisher]
	Bibliometric analysis of breast phantom development and image quality evaluation in breast imaging: Trends, collaboration networks, and research hotspots. Radiography (Lond) Susanti S, Astuty SD, Dewang S, Hartina S, Syarifuddin S. PMID: 41314128 [PubMed - as supplied by publisher]
	Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant. Breast Schreurs MAC, Adank MA, Heemskerk-Gerritsen BAM, Hollestelle A, Smallenbroek N, van Asperen CJ, Ausems MGEM, van de Beek I, de Bock GH, Boere I, van Hest LP, van Kaam KJAF, de Munck L, Vos JR, Jager A, Schmidt MK, Hooning MJ, Hebon. PMID: 41314031 [PubMed - as supplied by publisher]
	Real-world outcomes with palbociclib, ribociclib, and abemaciclib plus endocrine therapy in HR+/HER2- advanced breast cancer: A multicenter retrospective study. Breast Duchnowska R, Soter K, Pogoda K, Smok-Kalwat J, Grela-Wojewoda A, Winsko-Szcz, Kowalewska-Felczak A, Szwiec M, Danielewicz I, Streb J, Lewandowski T, Szymanowski B, Kiszka J, Radecka B, Kalinka E, Sobocki BK, Litwiniuk M, , Ba, , Ziobro M, Czartoryska-Ar, Ramlau R, My, Lipiec P, Jurczyk M, Kade G, , Huda, Szymanik-Resko M, Kustra E, Koriat-B, Tomasik B, Bie, Jassem J. PMID: 41314030 [PubMed - as supplied by publisher]
	Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03. Breast Trédan O, Loirat D, Chabaud S, Toussaint P, Petit T, Viret F, Levy C, Robert A, Grenier J, Mansi L, Spano JP, Patsouris A, Derbel O, Jouannaud C, Ferrero JM, Frenel JS, Molin Y, Doublet L, Heudel PE, Pierga JY, Garin G, Pérol D, Bachelot T. PMID: 41314029 [PubMed - as supplied by publisher]
	A scoping review of communication tools for risk-based breast cancer screening. Patient Educ Couns Hudson C, Isauiter J, Houssami N, Marinovich ML, Brooks J, Noguchi N, Nickel B. PMID: 41313996 [PubMed - as supplied by publisher]
	Long-term outcome data for patients with hormone receptor-positive early breast cancer participating in the WSG PlanB trial after preselection by gene expression analysis: 10-year survival results from the WSG PlanB registry. ESMO Open Nitz U, Graeser M, Gluz O, Kümmel S, Just M, Jackisch C, Zu Eulenburg C, Christgen M, Harbeck N, West German Study Group. PMID: 41313970 [PubMed - as supplied by publisher]
	Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX). ESMO Open Link T, Reinisch M, Just M, Untch M, Filmann N, Stötzer O, Denkert C, Bjelic-Radisic V, Wimberger P, Thill M, Rhiem K, Huober J, Solbach C, Hanusch C, Engels K, Fasching PA, Schneeweiss A, Nekljudova V, Holtschmidt J, Blohmer JU, Loibl S. PMID: 41313969 [PubMed - as supplied by publisher]
	Photodynamic therapy reduced stemness and cell migration in triple-negative breast cancer cells through the PTEN/CD44 signaling pathway: A comparative study. Biochem Biophys Res Commun Doustvandi MA, Khoshechin SB, Mohammadnejad F, Khiabani NA, Nobari SA, Yari AH, Mousavi P, Amini M, Baradaran B, Aghebati Maleki L. PMID: 41313945 [PubMed - as supplied by publisher]
	Parathyroid Hormone (1-34) Signaling for Bone Health in Breast Cancer Survivorship and Metastasis. J Cell Physiol Oh S, Oh HR, Shen C, Park YR, Park JH. PMID: 41313743 [PubMed - indexed for MEDLINE]
	Therapeutic potential of inhibitors of gelatinases MMP-2 and MMP-9 for the treatment of breast cancer. FEBS J Shoari A, Coban MA, Radisky ES. PMID: 41313679 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 212340

Seite 1 von 10617

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung